Literature DB >> 10027526

Reactive angioendotheliomatosis in an infant.

V Brazzelli1, F Baldini, C Vassallo, F Borghini, M G Chiesa, R Rosso, G Borroni.   

Abstract

Reactive cutaneous angioendotheliomatosis (RCA) is an uncommon benign disease characterized by intravascular proliferation of endothelial cells. The observation of RCA in infants is exceedingly rare. We describe a case of RCA in a 3-month-old infant. The lesions were characterized by six small purpuric papules (1-2 mm in diameter), distributed on the thighs and neck. The general condition of the patient was good, with no lymphadenopathy, systemic involvement, or fever. The histopathologic features of a papule were characterized by the presence of cohesive aggregates of large mononucleated cells protruding into the lumina of dilated vessels and filling some of them completely. Neither an inflammatory infiltrate nor a proliferation of pericytes were present around blood vessels. Intravascular proliferating cells demonstrated positive staining for Ulex europaeus agglutinin 1 (UEA-1) and for Factor VIII-RA and CD34 antigens. The course of the disease was unremarkable with persistence of the lesions for 8 months; no treatment was started.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027526     DOI: 10.1097/00000372-199902000-00010

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  2 in total

1.  Eruptive Pseudoangiomatosis: Clinicopathological Report of 20 Adult Cases and a Possible Novel Association with Parvovirus B19.

Authors:  Fatima Maqsood; Camilla Vassallo; Federica Derlino; Giorgio Alberto Croci; Christian Ciolfi; Valeria Brazzelli
Journal:  Acta Derm Venereol       Date:  2021-02-16       Impact factor: 3.875

2.  Dabska tumor (endovascular papillary angioendothelioma) of testis: a case report with brief review of literature.

Authors:  Alka Bhatia; Ritambra Nada; Yashwant Kumar; Prema Menon
Journal:  Diagn Pathol       Date:  2006-07-22       Impact factor: 2.644

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.